EP0856057A2 - Polynucleotide and encoded protein useful in controlling of melolontha sp. scarabs - Google Patents
Polynucleotide and encoded protein useful in controlling of melolontha sp. scarabsInfo
- Publication number
- EP0856057A2 EP0856057A2 EP96945813A EP96945813A EP0856057A2 EP 0856057 A2 EP0856057 A2 EP 0856057A2 EP 96945813 A EP96945813 A EP 96945813A EP 96945813 A EP96945813 A EP 96945813A EP 0856057 A2 EP0856057 A2 EP 0856057A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- protein
- polynucleotide
- proteins
- bacillus
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 53
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 52
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 34
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 34
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 34
- 241000254071 Melolontha Species 0.000 title claims abstract description 7
- 241000130993 Scarabaeus <genus> Species 0.000 title description 3
- 241001310339 Paenibacillus popilliae Species 0.000 claims abstract description 29
- 101710151559 Crystal protein Proteins 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 241000894007 species Species 0.000 claims abstract description 6
- 238000012217 deletion Methods 0.000 claims abstract description 4
- 230000037430 deletion Effects 0.000 claims abstract description 4
- 238000003780 insertion Methods 0.000 claims abstract description 4
- 230000037431 insertion Effects 0.000 claims abstract description 4
- 238000006467 substitution reaction Methods 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 36
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 17
- 239000013078 crystal Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 108020004414 DNA Proteins 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 230000002147 killing effect Effects 0.000 claims description 7
- 239000013612 plasmid Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 230000006798 recombination Effects 0.000 claims description 6
- 238000005215 recombination Methods 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 108020004511 Recombinant DNA Proteins 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 230000001418 larval effect Effects 0.000 claims description 4
- 241000192125 Firmicutes Species 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 210000004347 intestinal mucosa Anatomy 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 2
- 230000002538 fungal effect Effects 0.000 claims description 2
- 102000037865 fusion proteins Human genes 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 230000010354 integration Effects 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 210000004215 spore Anatomy 0.000 claims 2
- 210000004666 bacterial spore Anatomy 0.000 claims 1
- 230000001461 cytolytic effect Effects 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 241000254099 Melolontha melolontha Species 0.000 abstract description 17
- 241000254062 Scarabaeidae Species 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 19
- 239000012634 fragment Substances 0.000 description 8
- 241000254173 Coleoptera Species 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- 241000254101 Popillia japonica Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000028070 sporulation Effects 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241001529716 Entomophaga Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000868880 Homo sapiens Serpin B13 Proteins 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241000828959 Melolontha hippocastani Species 0.000 description 1
- 241000243190 Microsporidia Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 102100032322 Serpin B13 Human genes 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 241000385736 bacterium B Species 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000013452 biotechnological production Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000004763 spore germination Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Definitions
- the invention relates to isolated polynucleotides and the proteins encoded by them, and their use for combating hawthorn beetles (Scarabaeidae).
- the invention also relates to a method for producing these proteins
- Greenhorn beetles such as the field cockchafer (Melolontha melolontha) or the forest cockchafer (Melolontha hippocastan ⁇ ) and especially their larvae (grubs) can cause great damage in agricultural and forestry crops. Since their control by chemical insecticides is difficult and environmentally harmful, efforts are being made to an increasing extent to control the multiplication and spread of these insects using biological agents. For example, EP 633936 A1 describes a method in which vegetative cells, spores or protein crystals of certain strains of Bacillus thurmgiensis are used to control hawthorn beetles. The effectiveness of this method is, however, effective not satisfying
- B. popilliae is the causative agent of the so-called Milky Disease in larvae of cockchafer and other hawthorn beetles.
- the larvae infected with the Bacillus have high concentrations of vegetative cells and sporangia of B. popilliae in their hamolymph, which cause a milky white discoloration of the grub
- the bacterium B. popilliae is characterized, among other things, by the fact that it does not form catalase, most isolates are resistant to the antibiotic vancomycin and, during sporulation, form a conspicuous protein crystal, which is arranged inside the spindle-shaped sporangium next to the actual spore in its capacity as a pathogen B. popilliae has a high specificity for scarabaeids.
- the B. popilliae subspecies isolated from different scarabaeid species differ in part considerably in their growth properties, the composition of the protein crystal and their plasmids
- Bafer larvae are infected with B. popilliae by ingestion of the sp ⁇ rangia in the larvae, the spores germinate, and the vegetative bacterial cells penetrate through the intestinal epithelium and the basement membrane into the hamolymph and then multiply there over the next three to four weeks sporulate the B. popilliae cells, which ultimately leads to the death of the kafer larva
- B. popilliae forms predominantly vegetative cells and only exceptionally spores under in vitro conditions.
- WO 87 05 928 describes a method for obtaining the spores in vitro, in which the vegetative cells of B.
- popilliae in one defined medium can be cultivated and finally stimulated to sporulation by adding a certain adjuvant, but even with this method only a sporulation rate of about 80% is achieved.
- a considerable amount of equipment and personnel is consequently required and financial effort required, which makes this method economically unprofitable and therefore unsuitable for practice It is therefore an object of the present invention to provide biological agents for controlling scarabids which allow satisfactory control of these pests and which are technically simple and inexpensive to produce even in large quantities
- polynucleotides which encode proteins which are identical or at least related to the crystal proteins which are characteristic of Bacillus popilliae, and which fully or partially or by way of substitution represent the nucleotide sequence shown in the sequence listing SEQ ID NO: 1 , Deletion, insertion and / or inversion of a nucleotide sequence derived therefrom or a nucleotide sequence which hybridizes wholly or partly therewith.
- polynucleotides according to the invention themselves can either be obtained from a natural source or can also be produced synthetically or semi-synthetically.
- telomeres are preferably present as a component of a recombinant DNA vector molecule which has the ability to express the crystal protein or protein crystal characteristic of Bacillus popilliae or a protein related thereto in a prokaryotic or eukaryotic cell.
- This vector molecule has the advantage, inter alia, that it can be introduced into any cell, for example a commercially available, easy-to-cultivate bacterial culture of E. coli or Bacillus thuringiensis, subjected to a promoter which is already present in or incorporated into the cell and can be both replicated and expressed as Vector molecules are particularly suitable for plasmids derived from gram-positive bacteria
- the use of transformed host cells which contain a polynucleotide according to the invention which is coupled to a promoter which is naturally contained in the host cell or as a result of a recombination.
- Polynucleotide (s) are introduced into the host organism, ie into a microorganism, a virus, a protozoon, a plant cell or the like, for example by transformation, transduction or conjugation, integrated into the genetic material of these cells or viruses and brought to expression
- Bacillus thunngiensis for example Bacillus thunngiensis subsp kurstaki, have proven to be particularly suitable host cells. Bacillus thunngiensis has been very well studied and it is comparatively easy to produce the crystal protein of B. popilliae in large amounts in this system
- the protein (s) according to the invention can be used alone or in combination with at least one other substance as a biological insecticide for combating scarabids, ie for inhibiting feeding and / or killing adult and / or larval scarabids, in particular Melolontha - Types and species closely related to them.
- substance here includes chemical and biological materials including microorganisms.
- pathogens such as viruses, rickettsia, bacteria, fungi, microsporidia and others can result in an advantageous increase in the crystal toxin effect
- the proteins according to the invention are used together with spores of Bacillus popilliae and / or Bacillus thunngiensis.
- Bacillus sphaericus spores are also well suited
- Another, also very advantageous variant provides that the proteins according to the invention are used in combination with cytolysing proteins and / or receptor proteins for the intestinal epithelium of scarabaeids, preferably in the form of fusion proteins
- proteins according to the invention are used in combination with fungal spores
- one or more of the polynucleotides according to the invention infiltrates (transforms) into a microorganism (e.g. a bacterium, virus, fungus or protozoan) or into a cell of an animal or plant cell culture Control and control of a promoter contained in this microorganism or in this cell, naturally or as a result of a recombination, preferably subject to regulation and expression.
- a microorganism e.g. a bacterium, virus, fungus or protozoan
- Control and control of a promoter contained in this microorganism or in this cell naturally or as a result of a recombination, preferably subject to regulation and expression.
- the polynucleotide (s) is introduced into a bacterium of the Bacillus thunngiensis type
- the invention also encompasses the possibility of transferring polynucleotides according to the invention into plants or parts of plants in order to protect them against scarab acid seizure.
- it also includes the use of polynucleotides according to the invention for the production of transgenic plants with the property of a knee protein in all or some plant tissues to synthesize, which is similar or similar to the crystal protein characteristic of Bacillus popilliae, and which inhibits the feeding and / or killing of larval and / or adult Scarabaeids, in particular Melolontha species and closely related to them Species is suitable and / or also for inactivating and / or killing such soil organisms which damage plants and / or fungi and / or transmit diseases
- a method for the production of plants or plant tissues or plant propagation material with recombined genetic material, which comprises a heterologous polynucleotide according to the invention, the expression of which leads to a protein which is similar or similar to the crystal protein which occurs naturally and characteristically in Bacillus popilliae.
- This method according to the invention is characterized in that plant cells or plant tissue are transformed with a recombinant DNA which contains a polynucleotide according to the invention and additional regulatory nucleotide sequences which can bring about the stable integration and expression of the polynucleotide in the plant cells in that the plant or whose propagation material or both are then regenerated from the plant cells or the corresponding tissue transformed with the heterologous DNA, and that, if appropriate, this regenerated plant or its propagation material or both is biologically reproduced.
- Example 1 The invention is explained in more detail below on the basis of exemplary embodiments Example 1:
- a strain of Bacillus popilliae subsp melolonthae is isolated from white grubs of Melolontha melolontha.
- the common DNA methods are used to prepare the total DNA material from the bacterial cells of this strain, on the one hand, the crystal protein is isolated, purified and its amino acid sequence (in a commercially available protein sequencer) is determined.
- Corresponding oligonucleotides are synthesized for partial sequences from the two end regions of the protein in order to serve in a polymerase chain reaction (PCR) as a primer for the synthesis of a DNA probe for the crystal protein gene.
- the PCR is carried out using the total DNA from Bacillus popilliae subsp melolonthae
- the isolated crystal protein can also first be split into short fragments, then the amino acid sequence of some of these fragments determined and, by comparison with the amino acid sequence of the Cry II A protein from Bacillus thunngiensis known in the prior art, two fragments which are presumably from the two end regions selected of the protein.
- the DNA sequences corresponding to these fragments are then provided as oligonucleotides and used as primers for the PCR synthesis
- the product of the PCR is used as a probe for hybridization in the Southern blot.
- a 5.3 kB Eco RI fragment of the Bacillus poptllae genome is identified.
- the 5.3 kB Eco RI fragment is e.g. incorporated into the plasmid pBCSK + and cloned into the E. coli strain XL 1 Blue MRF '.
- the 5.3 kB Eco RI fragment of the Bacillus popilliae genome obtained according to Example 1 is incorporated into a plasmid for gram-positive bacteria and introduced into bacterial cells of a crystal-free strain of Bacillus thunngiensis subsp kurstaki.
- a plasmid is particularly suitable as a cloning vector for Bacillus thunngiensis known plasmid such as pHT304, pHT315 or pHT370, the preparation of which is described in the publication by O Arantes and D Lerecius in Gene, 148 (1991), pages 115-1 19. Reference is made to this publication in this respect and its content is hereby incorporated into the present description included
- Recombined bacteria are multiplied or cloned and, if necessary, stimulated to synthesize the crystal protein. This is done by inducing spore formation, preferably simply by changing the culture conditions in a targeted manner. Then the protein release is induced, for example by changing the culture conditions again, by spore germination or autolysis of the sporangia The protein released is separated from the culture medium, purified and, if necessary, stored in a cool, dry and dark place until use
- crystal protein according to the invention for controlling adult Scarabaeids of the species Melolontha melolontha.
- Cockchafer grubs (Melolontha melolontha) were dug up in the field, kept individually in breeding vessels in the laboratory and fed with carrot slices. After 3 weeks, 10 animals were fed the protein according to the invention in an aqueous suspension with or without spores. Just a day later, the feed intake was greatly reduced, inhibited
- the preparation is introduced into the soil, possibly in combination with other pathogens and preferably together with bait.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Insects & Arthropods (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19540223 | 1995-10-18 | ||
DE19540223 | 1995-10-18 | ||
PCT/DE1996/001979 WO1997014798A2 (en) | 1995-10-18 | 1996-10-17 | Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0856057A2 true EP0856057A2 (en) | 1998-08-05 |
Family
ID=7776053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96945813A Withdrawn EP0856057A2 (en) | 1995-10-18 | 1996-10-17 | Polynucleotide and encoded protein useful in controlling of melolontha sp. scarabs |
Country Status (7)
Country | Link |
---|---|
US (1) | US6204057B1 (en) |
EP (1) | EP0856057A2 (en) |
JP (1) | JPH11513563A (en) |
AU (1) | AU708689B2 (en) |
CA (1) | CA2235075A1 (en) |
DE (1) | DE19642729C2 (en) |
WO (1) | WO1997014798A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033993B2 (en) | 2001-04-13 | 2006-04-25 | Dainippon Ink And Chemicals, Inc. | Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects |
EP1277763B1 (en) * | 2001-07-04 | 2006-12-20 | Dainippon Ink And Chemicals, Inc. | Polypeptides having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotides encoding the same |
US7364728B2 (en) * | 2004-03-01 | 2008-04-29 | Phyllom Llc | Recombinant organisms producing insect toxins and methods for constructing same |
US10743535B2 (en) | 2017-08-18 | 2020-08-18 | H&K Solutions Llc | Insecticide for flight-capable pests |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824671A (en) * | 1986-03-24 | 1989-04-25 | Reuter Laboratories, Inc. | In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions |
US5185148A (en) * | 1991-12-16 | 1993-02-09 | Mycogen Corporation | Process for controlling scarab pests with Bacillus thuringiensis isolates |
-
1996
- 1996-10-17 WO PCT/DE1996/001979 patent/WO1997014798A2/en not_active Application Discontinuation
- 1996-10-17 JP JP9515423A patent/JPH11513563A/en not_active Ceased
- 1996-10-17 EP EP96945813A patent/EP0856057A2/en not_active Withdrawn
- 1996-10-17 CA CA002235075A patent/CA2235075A1/en not_active Abandoned
- 1996-10-17 AU AU17163/97A patent/AU708689B2/en not_active Ceased
- 1996-10-17 DE DE19642729A patent/DE19642729C2/en not_active Expired - Fee Related
-
1999
- 1999-09-29 US US09/408,820 patent/US6204057B1/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO9714798A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997014798A2 (en) | 1997-04-24 |
DE19642729A1 (en) | 1997-04-24 |
WO1997014798A3 (en) | 1997-10-23 |
CA2235075A1 (en) | 1997-04-24 |
US6204057B1 (en) | 2001-03-20 |
JPH11513563A (en) | 1999-11-24 |
AU708689B2 (en) | 1999-08-12 |
AU1716397A (en) | 1997-05-07 |
DE19642729C2 (en) | 1999-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69837906T2 (en) | INSECTICIDES PROTEINTOXIN OF XENORHABUS | |
DE69227911T2 (en) | NEW MICROORGANISM AND INSECTICIDE | |
DE69931511T2 (en) | PLANT-OPTIMIZED POLYNUCLEOTIDES CODING FOR 15KDA AND 45KDA PESTICIDE PROTEINS | |
DE69111600T2 (en) | BACILLUS THURINGIENSIS-CRYIIIC GENE AND FOR COLEOPTERA INSECT TOXIC PROTEIN. | |
DE69530194T2 (en) | CHIMERAL DELTA-ENDOTOXIN EXPRESSION IN PSEUDOMONAS FLUORESCENS | |
DE68918477T2 (en) | Hybrids of Bacillus thuringiensis, plasmids and transformed Pseudomonas fluorescens. | |
DE69635307T2 (en) | INDUCED RESISTANCE AGAINST SENSITIVITY REACTIONS IN PLANTS | |
DE69025808T2 (en) | Isolate from Bacillus thuringiensis, which is active against Lepidoptera pests, and genes which code for the new lepidoptera-active toxins | |
DE3685968T2 (en) | CELLULAR ENCLOSURE OF BIOLOGICAL PESTICIDES. | |
DE69737196T2 (en) | PESTICIDES | |
DE60022224T2 (en) | BACILLUS THURINGIENSIS TOXIN ACTIVE AGAINST FORMICIDAE (ANT) | |
DE3850180T2 (en) | Bacteriocides and / or bacteriostatic peptides, processes for their isolation, production and use. | |
DE3650705T2 (en) | Microorganisms as pesticides | |
DE3689753T2 (en) | AGRICULTURAL CHEMICALS PRODUCING ENDOSYMBIOTIC MICROORGANISMS AND THEIR PRODUCTION AND USE. | |
DE19532001A1 (en) | New antibacterial peptide, moricin, from silkworms | |
DE3485964T2 (en) | AGRICULTURAL CHEMICALS PRODUCING ENDOSYMBIOTIC BACTERIA AND METHOD FOR THE PRODUCTION AND USE THEREOF. | |
DE60222027T2 (en) | CHIMERIC DELTA ENDOTOXINS PROTEIN CRY1EA AND CRY1CA | |
DE60034879T2 (en) | lantibiotic | |
AU606939B2 (en) | Hybrid genes incorporating a dna fragment containing a gene coding for an insecticidal protein, plasmids, transformed cyanobacteria expressing such protein and method for use as a biocontrol agent | |
DE69220791T2 (en) | NEW BACILLUS-THURINGIENSIS ISOLATE FOR CONTROLLING ACARIDES | |
DE69219615T2 (en) | AGAINST SCRAPS ACTIVE BACILLUS THURINGIENSIS ISOLATES AND GENES ENCODING RAPID-ACTIVE TOXINS | |
DE3853652T2 (en) | Nucleotide sequences encoding polypeptides endowed with larvicidal activity against lepidopterans. | |
DE19642729C2 (en) | Polynucleotides and the proteins encoded by them, suitable for controlling hawthorn beetles | |
DE69905278T2 (en) | INSECTICIDE AGENT | |
DE69524954T2 (en) | AGAINST SCRAPS ACTIVE BACILLUS THURINGIENSIS ISOLATE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980406 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B. Owner name: NOVARTIS AG |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SYNGENTA PARTICIPATIONS AG |
|
17Q | First examination report despatched |
Effective date: 20031010 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040223 |